News Vertex, AbCellera Partner on Next-Generation T-Cell Engagers for Autoimmune Disease pharminent July 29, 2026
M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026
News GSK Unveils Three-Year Restructuring to Fund Late-Stage R&D Ahead of Patent Cliff pharminent July 28, 2026
Clinical Data Altimmune rises as GLP-1/GIP drug curbs heavy drinking in mid-stage study pharminent July 28, 2026
News AstraZeneca Says Drug Pricing Is ‘Evolving’ in Response to Trump’s Most-Favored-Nation Policy pharminent July 27, 2026
M&A / Deals Argenx deepens immuno expertise with $2.2B Forte Biosciences buy pharminent July 27, 2026
News EMA CHMP Recommends Twelve New Medicines for Approval at July 2026 Meeting pharminent July 24, 2026
News Lilly’s Retatrutide Hits 22.6% Weight Loss in Phase 3, But Cardiovascular Benefit Remains Elusive pharminent July 23, 2026
Regulatory GSK’s $10.6B Nuvalent bet pays off early as FDA approves lung cancer drug pharminent July 23, 2026
News Arrowhead’s Plozasiran Cuts Triglycerides Roughly 80% in Two Phase 3 Trials pharminent July 22, 2026
Clinical Data Arrowhead hits ‘best-case scenario’ with latest results for fat-lowering drug pharminent July 22, 2026
Manufacturing Speciality versus diversity: the four-way CDMO race in outsourced HPAPI manufacturing pharminent July 22, 2026
Manufacturing Samsung Biologics: geographic diversification is a sound business decision pharminent July 22, 2026
Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026
Manufacturing Cellares and Papillon partner for PPL-001 manufacturing automation pharminent July 22, 2026
News Samsung Biologics Acquires Swiss CDMO PolyPeptide in $1.81bn All-Cash Deal pharminent July 20, 2026
M&A / Deals Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelics pharminent July 20, 2026
Clinical Data GSK culls cough program for drug at the heart of $2B Bellus bet after Phase 3 fail pharminent July 17, 2026
News Merck Wins First FDA Approval of an Oral PCSK9 Inhibitor with Cholesterol Pill Lipfendra pharminent July 16, 2026